UBS Group’s Carlsmed CARL Stock Holding History
Bought
Maintained
Sold
Other funds holding CARL
UBS Group's CARL Position: Q3 2026 in Review
UBS Group reduced its Carlsmed (CARL) stake by 27% in Q3 2026, selling an estimated $63.6K and leaving 12,168 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #6857.
UBS Group first reported a position in CARL in Q3 2025 and has held it in 5 quarters since. The position peaked at $324K in Q3 2025. 86 funds tracked by Wall St. Rank hold CARL as of Q3 2026.
- UBS Group held 12,168 shares of Carlsmed worth $171K as of Q3 2026.
- UBS Group sold 4,581 Carlsmed shares in Q3 2026, an estimated $63.6K.
- Carlsmed made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6857 holding.
- UBS Group first reported a position in Carlsmed in Q3 2025 and has held it in 5 quarters since.
- UBS Group's Carlsmed position peaked at $324K in Q3 2025.
- 86 funds tracked by Wall St. Rank held Carlsmed as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.